Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Link

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Nature Communications|July 30, 2020
Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Acquired copy number alterations in adult acute myeloid leukemia genomesMatthew J Walter, Jacqueline E Payton, Rhonda E Ries, et al.
Nature Genetics|December 14, 2011
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesTimothy A Graubert, Dong Shen, Li Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Experimental Hematology|May 17, 2016
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaMalachi Griffith, Obi L Griffith, Kilannin Krysiak, et al.
Nature Genetics|July 15, 2025
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancyJie Liu, Duc Tran, Liying Xue, et al.
Nature|January 13, 2012
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingLi Ding, Timothy J Ley, David E Larson, et al.
The New England Journal of Medicine|December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S Welch, Allegra A Petti, Christopher A Miller, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Nature Communications|July 30, 2020
Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathwaySisi Chen, Qiang Wang, Hao Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Acquired copy number alterations in adult acute myeloid leukemia genomesMatthew J Walter, Jacqueline E Payton, Rhonda E Ries, et al.
Nature Genetics|December 14, 2011
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesTimothy A Graubert, Dong Shen, Li Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Experimental Hematology|May 17, 2016
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaMalachi Griffith, Obi L Griffith, Kilannin Krysiak, et al.
Nature Genetics|July 15, 2025
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancyJie Liu, Duc Tran, Liying Xue, et al.
Nature|January 13, 2012
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingLi Ding, Timothy J Ley, David E Larson, et al.
The New England Journal of Medicine|December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S Welch, Allegra A Petti, Christopher A Miller, et al.
Pageof 17